Skip to menu Skip to content Skip to footer

2025

Journal Article

Lower-limb biomechanics in motor neuron disease: a joint-level perspective of gait disruption

Holdom, Cory J., Williamson, James L., O’Reilly, Georgia, Henderson, Robert D., Neville, Sally, Ngo, Shyuan T., Dick, Taylor J. M. and Steyn, Frederik J. (2025). Lower-limb biomechanics in motor neuron disease: a joint-level perspective of gait disruption. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 1-11. doi: 10.1080/21678421.2025.2523945

Lower-limb biomechanics in motor neuron disease: a joint-level perspective of gait disruption

2025

Journal Article

An annotated multi-site and multi-contrast magnetic resonance imaging dataset for the study of the human tongue musculature

Ribeiro, Fernanda L., Zhu, Xiangyun, Ye, Xincheng, Tu, Sicong, Ngo, Shyuan T., Henderson, Robert D., Steyn, Frederik J., Kiernan, Matthew C., Barth, Markus, Bollmann, Steffen and Shaw, Thomas B. (2025). An annotated multi-site and multi-contrast magnetic resonance imaging dataset for the study of the human tongue musculature. Scientific Data, 12 (1) 790, 790. doi: 10.1038/s41597-025-05092-8

An annotated multi-site and multi-contrast magnetic resonance imaging dataset for the study of the human tongue musculature

2025

Journal Article

An fMRI dataset for appetite neural correlates in people living with Motor Neuron Disease

Chang, Jeryn, Lv, JingLei, Guo, Christine C., Lucia, Diana, Bollmann, Saskia, Garner, Kelly, McCombe, Pamela A., Henderson, Robert D., Shaw, Thomas B., Steyn, Frederik J. and Ngo, Shyuan T. (2025). An fMRI dataset for appetite neural correlates in people living with Motor Neuron Disease. Scientific Data, 12 (1) 466, 466. doi: 10.1038/s41597-025-04828-w

An fMRI dataset for appetite neural correlates in people living with Motor Neuron Disease

2025

Journal Article

Appetite loss in patients with motor neuron disease: impact on weight loss and neural correlates of visual food cues

Chang, Jeryn, Shaw, Thomas B., McCombe, Pamela A., Henderson, Robert D., Lucia, Diana, Guo, Christine C., Lv, Jinglei, Garner, Kelly, Bollmann, Saskia, Ngo, Shyuan T. and Steyn, Frederik J. (2025). Appetite loss in patients with motor neuron disease: impact on weight loss and neural correlates of visual food cues. Brain Communications, 7 (2) fcaf111, 1-14. doi: 10.1093/braincomms/fcaf111

Appetite loss in patients with motor neuron disease: impact on weight loss and neural correlates of visual food cues

2025

Journal Article

Persistent high levels of perceived fatigue are not associated with hypermetabolism in patients with amyotrophic lateral sclerosis

Buckett, Lauren E., Holdom, Cory J., Howe, Stephanie L., McCombe, Pamela A., Henderson, Robert D., Al-Chalabi, Ammar, Steyn, Frederik J. and Ngo, Shyuan T. (2025). Persistent high levels of perceived fatigue are not associated with hypermetabolism in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, ahead-of-print (ahead-of-print), 1-10. doi: 10.1080/21678421.2025.2471429

Persistent high levels of perceived fatigue are not associated with hypermetabolism in patients with amyotrophic lateral sclerosis

2025

Journal Article

Routine blood biochemical biomarkers in amyotrophic lateral sclerosis: Systematic review and cohort analysis

Nona, Robert J., Henderson, Robert D. and McCombe, Pamela A. (2025). Routine blood biochemical biomarkers in amyotrophic lateral sclerosis: Systematic review and cohort analysis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (3-4), 1-19. doi: 10.1080/21678421.2024.2435976

Routine blood biochemical biomarkers in amyotrophic lateral sclerosis: Systematic review and cohort analysis

2024

Journal Article

Evaluation of NUN-004, a novel engineered ephrin antagonist, in healthy volunteers and patients with amyotrophic lateral sclerosis: a phase I/Ib, open-label, escalating dose and extended access study

Gerometta, Michael, Henderson, Robert D., Friend, Richard, Cooper, Leanne T., Zhao, Jing, Boyd, Andrew W. and Bartlett, Perry F. (2024). Evaluation of NUN-004, a novel engineered ephrin antagonist, in healthy volunteers and patients with amyotrophic lateral sclerosis: a phase I/Ib, open-label, escalating dose and extended access study. Clinical Drug Investigation, 45 (1) e24636, 17-28. doi: 10.1007/s40261-024-01410-x

Evaluation of NUN-004, a novel engineered ephrin antagonist, in healthy volunteers and patients with amyotrophic lateral sclerosis: a phase I/Ib, open-label, escalating dose and extended access study

2024

Journal Article

Central neurodegeneration in Kennedy’s disease accompanies peripheral motor dysfunction

Tu, Sicong, Li, Tiffany, Carroll, Antonia S., Mahoney, Colin J., Huynh, William, Park, Susanna B., Henderson, Robert, Vucic, Steve, Kiernan, Matthew C. and Lin, Cindy S-Y (2024). Central neurodegeneration in Kennedy’s disease accompanies peripheral motor dysfunction. Scientific Reports, 14 (1) 18331, 18331. doi: 10.1038/s41598-024-69393-5

Central neurodegeneration in Kennedy’s disease accompanies peripheral motor dysfunction

2024

Conference Publication

Patient reported measures as the optimal assessment of chemotherapy-induced peripheral neuropathy

Li, Tiffany, Timmins, Hannah C., Mahfouz, Fawaz M., Trinh, Terry, Mizrahi, David, Horvath, Lisa G., Harrison, Michelle, Grimison, Peter, Friedlander, Michael, Marx, Gavin, Boyle, Frances, Wyld, David, Henderson, Robert, King, Tracy, Baron-Hay, Sally, Kiernan, Matthew C., Rutherford, Claudia, Goldstein, David and Park, Susanna B. (2024). Patient reported measures as the optimal assessment of chemotherapy-induced peripheral neuropathy. COSA's 51st Annual Scientific Meeting Bridging gaps, building progress, breaking down disparities, Gold Coast, QLD, Australia, 13 - 15 November 2024. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.14116

Patient reported measures as the optimal assessment of chemotherapy-induced peripheral neuropathy

2024

Conference Publication

Clinical risk factors associated with development of significant nerve damage during chemotherapy

Li, Tiffany, Timmins, Hannah C., Horvath, Lisa G., Harrison, Michelle, Grimison, Peter, Friedlander, Michael, Marx, Gavin, Boyle, Frances, Wyld, David, Henderson, Robert, Baron-Hay, Sally, Kiernan, Matthew C., Barnes, Elizabeth H., Goldstein, David and Park, Susanna B. (2024). Clinical risk factors associated with development of significant nerve damage during chemotherapy. COSA's 51st Annual Scientific Meeting Bridging gaps, building progress, breaking down disparities, Gold Coast, QLD, Australia, 13 - 15 November 2024. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.14117

Clinical risk factors associated with development of significant nerve damage during chemotherapy

2024

Journal Article

Assessing the effect of Riluzole on motor unit discharge properties

Shandiz, Ehsan, Fernandes, Gabriel Lima, Henkin, Joao Saldanha, McCombe, Pamela Ann, Trajano, Gabriel Siqueira and Henderson, Robert David (2024). Assessing the effect of Riluzole on motor unit discharge properties. Brain Sciences, 14 (11) 1053, 1053. doi: 10.3390/brainsci14111053

Assessing the effect of Riluzole on motor unit discharge properties

2024

Journal Article

Diagnosing late-onset Tay-Sachs through next generation sequencing and functional enzyme testing: from genes to enzymes

Tupil, Ajay R., Rivlin, Warwick, Mccombe, Pamela A., Henderson, Robert D., Rodgers, Jonathan and Vadlamudi, Lata (2024). Diagnosing late-onset Tay-Sachs through next generation sequencing and functional enzyme testing: from genes to enzymes. Neurology Genetics, 10 (6) e200205, e200205. doi: 10.1212/nxg.0000000000200205

Diagnosing late-onset Tay-Sachs through next generation sequencing and functional enzyme testing: from genes to enzymes

2024

Journal Article

Generation of human induced pluripotent stem cell lines from sporadic, sporadic frontotemporal dementia, familial SOD1, and familial C9orf72 amyotrophic lateral sclerosis (ALS) patients

Jiang, Leanne, Tracey, Timothy J., Gill, Melinder K., Howe, Stephanie L., Power, Dominique T., Bharti, Vanda, McCombe, Pamela A., Henderson, Robert D., Steyn, Frederik J. and Ngo, Shyuan T. (2024). Generation of human induced pluripotent stem cell lines from sporadic, sporadic frontotemporal dementia, familial SOD1, and familial C9orf72 amyotrophic lateral sclerosis (ALS) patients. Stem Cell Research, 78 103447, 1-6. doi: 10.1016/j.scr.2024.103447

Generation of human induced pluripotent stem cell lines from sporadic, sporadic frontotemporal dementia, familial SOD1, and familial C9orf72 amyotrophic lateral sclerosis (ALS) patients

2024

Journal Article

Stepping up for a practical biomarker of motor unit loss

Henderson, Robert David and Shandiz, Ehsan (2024). Stepping up for a practical biomarker of motor unit loss. Muscle & Nerve, 70 (1), 1-3. doi: 10.1002/mus.28110

Stepping up for a practical biomarker of motor unit loss

2024

Conference Publication

Identifying optimized assessment of nerve damage during chemotherapy

Li, Tiffany, Timmins, Hannah C, Mahfouz, Fawaz Mayez, Mizrahi, David, Horvath, Lisa, Harrison, Michelle L., Grimison, Peter S., Friedlander, Michael, Marx, Gavin M., Boyle, Frances M., Wyld, David, Henderson, Robert, King, Tracy, Baron-Hay, Sally E., Kiernan, Matthew C, Rutherford, Claudia, Goldstein, David and Park, Susanna B (2024). Identifying optimized assessment of nerve damage during chemotherapy. 2024 ASCO Annual Meeting, Chicago, IL United States, 31 May - 4 June 2024. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2024.42.16_suppl.12016

Identifying optimized assessment of nerve damage during chemotherapy

2024

Journal Article

Verbal and nonverbal fluency in amyotrophic lateral sclerosis

Barker, Megan S., Ceslis, Amelia, Argall, Rosemary, McCombe, Pamela, Henderson, Robert D. and Robinson, Gail A. (2024). Verbal and nonverbal fluency in amyotrophic lateral sclerosis. Journal of Neuropsychology, 18 (2), 265-285. doi: 10.1111/jnp.12354

Verbal and nonverbal fluency in amyotrophic lateral sclerosis

2024

Journal Article

Neutrophil-to-lymphocyte ratio at diagnosis as a biomarker for survival of amyotrophic lateral sclerosis

Nona, Robert J., Henderson, Robert D. and McCombe, Pamela A. (2024). Neutrophil-to-lymphocyte ratio at diagnosis as a biomarker for survival of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 25 (5-6), 452-464. doi: 10.1080/21678421.2024.2351187

Neutrophil-to-lymphocyte ratio at diagnosis as a biomarker for survival of amyotrophic lateral sclerosis

2024

Journal Article

Variation in resting metabolic rate affects identification of metabolic change in geographically distinct cohorts of patients with ALS

Holdom, Cory J., Janse van Mantgem, Mark R., He, Ji, Howe, Stephanie L., McCombe, Pamela A., Fan, Dongsheng, van den Berg, Leonard H., Henderson, Robert D., van Eijk, Ruben, Steyn, Frederik J. and Ngo, Shyuan T. (2024). Variation in resting metabolic rate affects identification of metabolic change in geographically distinct cohorts of patients with ALS. Neurology, 102 (5) e208117, 1-11. doi: 10.1212/wnl.0000000000208117

Variation in resting metabolic rate affects identification of metabolic change in geographically distinct cohorts of patients with ALS

2024

Journal Article

Gut symptoms, gut dysbiosis and gut-derived toxins in ALS

Lee, Aven, Henderson, Robert, Aylward, James and McCombe, Pamela (2024). Gut symptoms, gut dysbiosis and gut-derived toxins in ALS. International Journal of Molecular Sciences, 25 (3) 1871, 1-25. doi: 10.3390/ijms25031871

Gut symptoms, gut dysbiosis and gut-derived toxins in ALS

2024

Journal Article

Associations of postprandial ghrelin, liver‐expressed antimicrobial peptide 2 and leptin levels with body composition, disease progression and survival in patients with amyotrophic lateral sclerosis

Howe, Stephanie L., Holdom, Cory J., McCombe, Pamela A., Henderson, Robert D., Zigman, Jeffrey M., Ngo, Shyuan T. and Steyn, Frederik J. (2024). Associations of postprandial ghrelin, liver‐expressed antimicrobial peptide 2 and leptin levels with body composition, disease progression and survival in patients with amyotrophic lateral sclerosis. European Journal of Neurology, 31 (1) e16052, e16052. doi: 10.1111/ene.16052

Associations of postprandial ghrelin, liver‐expressed antimicrobial peptide 2 and leptin levels with body composition, disease progression and survival in patients with amyotrophic lateral sclerosis